CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Having determined that BH3 mimetics induce apoptosis to a greater degree in BP-CML CD34+ population, which contains disease-driving leukemia stem cells, we investigated whether BH3 mimetics are able to decrease the functional colony-forming capacity of BP-CML cells.